Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast-Reference-Cited by-同舟云学术

Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast

Published:2022-05 Issue: Volume:218 Page:108966
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Honig Marcia G.,Del Mar Nobel A.,Henderson Desmond L.,O'Neal Dylan,Yammanur Meghna,Cox Rachel,Li Chunyan,Perry Aaron M.,Moore Bob M.,Reiner Anton^ORCID

Funder

National Eye Institute

US Department of Defense

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference78 articles.

1. Visual problems associated with traumatic brain injury;Armstrong;Clin. Exp. Optom.,2018

2. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration;Ashton;Curr. Neuropharmacol.,2007

3. Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration;Ban;J. Lipid Res.,2018

4. Two types of melanopsin retinal ganglion cell differentially innervate the hypothalamic suprachiasmatic nucleus and the olivary pretectal nucleus;Baver;Eur. J. Neurosci.,2008

5. New tools for studying microglia in the mouse and human CNS;Bennett;Proc. Natl. Acad. Sci. U.S.A.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds;Journal of Neuroinflammation;2023-03-19

2. Raloxifene Mitigates Emotional Deficits after Mild Traumatic Brain Injury in Mice;Neurotrauma Reports;2022-11-01